Results 101 to 110 of about 2,190,716 (112)
Some of the next articles are maybe not open access.
Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
Current pharmaceutical design, 2013Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and wound healing, stable in human gastric juice, with no toxicity being reported. Recently, we claim that BPC 157 may be used as an antidote against NSAIDs. We focused on BPC 157
Šebečić, Božidar +15 more
openaire +1 more source
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats
Current NeuropharmacologyThis review explores the therapeutic potential of the stable gastric pentadecapeptide BPC 157 in addressing electrolyte imbalances, specifically hyperkalemia, hypokalemia, hypermagnesemia, and hyperlithiemia.
Marija Medvidovic, Grubisic +21 more
openaire +2 more sources
Stable gastric pentadecapeptide BPC-157 heals transected muscle in rat.
Digestive diseases and sciences, 2003Stable gastric pentadecapeptide BPC-157 heals transected muscle in rat.
Staresinic, M. +15 more
openaire +2 more sources
Stable gastric pentadecapeptide BPC 157 may heal duodenocutaneous fistulas in rats
Gastroenterology (New York, N.Y. 1943), 2011We investigate the healing of duodenocutaneous fistulas in rats and stable gastric pentadecapeptide BPC 157. We recently focused on unhealed gastrocutaneous fistulas (2-mm-diameter stomach defect, 3-mm-diameter skin defect) to resolve whether standard drugs that promote healing of gastric ulcers may simultaneously have the same effect on cutaneous ...
Turković, Branko +8 more
openaire
The stable gastric pentadecapeptide BPC 157, given locally, improves CO laser healing in mice
Burns, 2005Predrag Sikiric
exaly

